Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pincus

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Immunological Investigations|January 1, 1997
HTLV-associated diseases: human retroviral infection and cutaneous T-cell lymphomasK Fujihara, B Goldman, A R Oseroff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1997
High-dose chemotherapy and autologous stem cell support followed by posttransplantation doxorubicin as initial therapy for metastatic breast cancerM deMagalhaes-Silverman, E Bloom, B Lembersky, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|April 15, 1989
Meningococcaemia complicated by myocarditis. A report of 2 casesM A Sandler, P S Pincus, M D Weltman, et al.
The Journal of Infectious Diseases|May 24, 2000
Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTLsZ Gyulai, V Endresz, K Burian, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 24, 2005
Repaglinide treatment amplifies first-phase insulin secretion and high-frequency pulsatile insulin release in Type 2 diabetesM Hollingdal, J Sturis, M-A Gall, et al.
Metabolism: Clinical and Experimental|July 26, 2000
Assessment of insulin secretion in relatives of patients with type 2 (non-insulin-dependent) diabetes mellitus: evidence of early beta-cell dysfunctionB Nyholm, N Pørksen, C B Juhl, et al.
Annals of the Rheumatic Diseases|August 17, 2004
First clinical trials of a new heteropolymer technology agent in normal healthy volunteers and patients with systemic lupus erythematosus: safety and proof of principle of the antigen-heteropolymer ETI-104C Iking-Konert, S Stocks, F Weinsberg, et al.
Vaccine|March 17, 1999
Induction of human cytomegalovirus (HCMV)-glycoprotein B (gB)-specific neutralizing antibody and phosphoprotein 65 (pp65)-specific cytotoxic T lymphocyte responses by naked DNA immunizationV Endresz, L Kari, K Berencsi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1995
Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigenK A Foon, A R Oseroff, L Vaickus, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1995
Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assayJ D Veldhuis, A Y Liem, S South, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Immunological Investigations|January 1, 1997
HTLV-associated diseases: human retroviral infection and cutaneous T-cell lymphomasK Fujihara, B Goldman, A R Oseroff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1997
High-dose chemotherapy and autologous stem cell support followed by posttransplantation doxorubicin as initial therapy for metastatic breast cancerM deMagalhaes-Silverman, E Bloom, B Lembersky, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|April 15, 1989
Meningococcaemia complicated by myocarditis. A report of 2 casesM A Sandler, P S Pincus, M D Weltman, et al.
The Journal of Infectious Diseases|May 24, 2000
Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTLsZ Gyulai, V Endresz, K Burian, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 24, 2005
Repaglinide treatment amplifies first-phase insulin secretion and high-frequency pulsatile insulin release in Type 2 diabetesM Hollingdal, J Sturis, M-A Gall, et al.
Metabolism: Clinical and Experimental|July 26, 2000
Assessment of insulin secretion in relatives of patients with type 2 (non-insulin-dependent) diabetes mellitus: evidence of early beta-cell dysfunctionB Nyholm, N Pørksen, C B Juhl, et al.
Annals of the Rheumatic Diseases|August 17, 2004
First clinical trials of a new heteropolymer technology agent in normal healthy volunteers and patients with systemic lupus erythematosus: safety and proof of principle of the antigen-heteropolymer ETI-104C Iking-Konert, S Stocks, F Weinsberg, et al.
Vaccine|March 17, 1999
Induction of human cytomegalovirus (HCMV)-glycoprotein B (gB)-specific neutralizing antibody and phosphoprotein 65 (pp65)-specific cytotoxic T lymphocyte responses by naked DNA immunizationV Endresz, L Kari, K Berencsi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1995
Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigenK A Foon, A R Oseroff, L Vaickus, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1995
Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assayJ D Veldhuis, A Y Liem, S South, et al.
Pageof 9